- Home
- STRM vs NXL Comparison
STRM vs NXL Comparison
Compare STRM & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- NXL
- Stock Information
- Founded
- STRM 1989
- NXL 2010
- Country
- STRM United States
- NXL United States
- Employees
- STRM N/A
- NXL N/A
- Industry
- STRM EDP Services
- NXL Medical Specialities
- Sector
- STRM Technology
- NXL Health Care
- Exchange
- STRM Nasdaq
- NXL Nasdaq
- Market Cap
- STRM 9.3M
- NXL 10.0M
- IPO Year
- STRM 1996
- NXL 2022
- Fundamental
- Price
- STRM $3.15
- NXL $3.82
- Analyst Decision
- STRM
- NXL Strong Buy
- Analyst Count
- STRM 0
- NXL 1
- Target Price
- STRM N/A
- NXL $3.00
- AVG Volume (30 Days)
- STRM 32.2K
- NXL 2.0M
- Earning Date
- STRM 12-11-2024
- NXL 11-08-2024
- Dividend Yield
- STRM N/A
- NXL N/A
- EPS Growth
- STRM N/A
- NXL N/A
- EPS
- STRM N/A
- NXL N/A
- Revenue
- STRM $20,301,000.00
- NXL $162,078.00
- Revenue This Year
- STRM N/A
- NXL $51.39
- Revenue Next Year
- STRM $4.04
- NXL $177.11
- P/E Ratio
- STRM N/A
- NXL N/A
- Revenue Growth
- STRM N/A
- NXL 26.00
- 52 Week Low
- STRM $1.85
- NXL $0.25
- 52 Week High
- STRM $9.75
- NXL $4.36
- Technical
- Relative Strength Index (RSI)
- STRM 57.65
- NXL 64.56
- Support Level
- STRM $2.82
- NXL $3.65
- Resistance Level
- STRM $3.72
- NXL $4.36
- Average True Range (ATR)
- STRM 0.36
- NXL 0.58
- MACD
- STRM 0.12
- NXL -0.04
- Stochastic Oscillator
- STRM 65.87
- NXL 72.45
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.